Seeking Alpha

Canaccord lowers Delcath's (DCTH -0.1%) price target to $5 from $8 on the back of its investor...

Canaccord lowers Delcath's (DCTH -0.1%) price target to $5 from $8 on the back of its investor meeting to reflect the recently announced delay of its NDA filing and dilution related to the company's recent secondary offering. The company maintains its Buy rating on the shares.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)